MedTrace Logo

Adjunctive Bright Light Therapy in Patients With Bipolar Depression and Eveningness

NCT05357313 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-03-05

No results posted yet for this study

Summary

This is a randomized placebo-controlled trial to examine the efficacy of six-week bright light therapy as adjunctive treatment for patient with bipolar depression and eveningness.

Conditions

Interventions

DEVICE

Bright light therapy

Exposure to 10,000lux bright light for 30minutes a day for six weeks

DEVICE

Inactive negative ion generator

Exposure to an inactive negative ion generator for 30 minutes a day for six weeks

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-02
Primary Completion
2025-11-28
Completion
2026-06-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05357313 on ClinicalTrials.gov